549
Views
147
CrossRef citations to date
0
Altmetric
Editorial

Emerging application of quantum dots for drug delivery and therapy

, PhD & , PhD
Pages 263-267 | Published online: 05 Mar 2008

Bibliography

  • Michalet X, Pinaud FF, Bentolila LA, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005;307(5709):538-44
  • Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labeling and sensing. Nat Mater 2005;4(6):435-46
  • Alivisatos P. The use of nanocrystals in biological detection. Nat Biotechnol 2004;22(1):47-52
  • Smith AM, Dave S, Nie S, et al. Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev Mol Diagn 2006;6(2):231-44
  • Wu X, Liu H, Liu J, et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003;21(1):41-6
  • Gao X, Cui Y, Levenson RM, et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004;22(8):969-76
  • Dubertret B, Skourides P, Norris DJ, et al. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002;298(5599):1759-62
  • Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998;281(5385):2016-8
  • Larson DR, Zipfel WR, Williams RM, et al. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 2003;300(5624):1434-6
  • Dahan M, Levi S, Luccardini C, et al. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 2003;302(5644):442-5
  • Lidke DS, Naqy P, Heintzmann R, et al. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat Biotechnol 2004;22(2):169-70
  • Soo Choi H, Liu W, Misra P, et al. Renal clearance of quantum dots. Nat Biotechnol 2007;25(10):1165-70
  • Manabe N, Hoshino A, Liang YQ, et al. Quantum dot as a drug tracer in vivo. IEEE Trans Nanobiosci 2006;5(4):263-7
  • Baqalkot V, Zhang L, Levy-Nissenbaum E, et al. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett 2007;7(10):3065-70
  • Derfus AM, Chen AA, Bhatia SN, et al. Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem 2007;18(5):1391-6
  • McNamara JO, Andrechek ER, Wang Y, et al. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol 2006;24(8):1005-15
  • Medarova Z, Pham W, Farrar C, et al. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 2007;13(3):372-7
  • Srinivasan C, Lee J, Papadimitrakopoulos F, et al. Labeling and intracellular tracking of functionally active plasmid DNA with semiconductor quantum dots. Mol Ther 2006;14(2):192-201
  • Chen AA, Derfus AM, Khetani SR, Bhatia SN. Quantum dots to monitor RNAi delivery and improve gene silencing. Nucleic Acids Res 2005;33(22):e190
  • Tan WB, Jiang S, Zhang Y. Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference. Biomaterials 2007;28(8):1565-71
  • Jia N, Lian Q, Shen H, et al. Intracellular delivery of quantum dots tagged antisense oligodeoxynucleotides by functionalized multiwalled carbon nanotubes. Nano Lett 2007;7(10):2976-80
  • Akin D, Sturgis J, Ragheb K, et al. Bacteria-mediated delivery of nanoparticles and cargo into cells. Nat Nanotechnol 2006;2:441-9
  • Remaut K, Lucas B, Braeckmans K, et al. Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides. J Control Rel 2007;117(2):256-66

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.